Perspective Therapeutics (CATX) Preferred Dividend Payments (2010 - 2020)
Perspective Therapeutics (CATX) reported Preferred Dividend Payments of $3000.0 for Q3 2020, little changed on a YoY basis from $3000.0 in Q4 2019, and little changed sequentially from $3000.0 in Q2 2020.
Perspective Therapeutics (CATX) Preferred Dividend Payments (2010 - 2020) Analysis & Trends
Perspective Therapeutics (CATX) has 11 years of Preferred Dividend Payments data on file, last reported at $3000.0 in Q3 2020.
- For the quarter ending Q3 2020, Preferred Dividend Payments changed 0.0% year-over-year to $3000.0; the trailing twelve-month figure through Jun 2021 stood at $3000.0 (down 72.73% YoY), and the FY2021 full-year result was $3000.0, down 72.73% from the prior year.
- Preferred Dividend Payments was little changed at $3000.0 in Q3 2020, from $3000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $3000.0 in Q1 2016 to a low of $2000.0 in Q4 2016.
- A 5-year average of $2842.1 and a median of $3000.0 in 2016 frame the typical range for Preferred Dividend Payments.
- Across the five-year window, Preferred Dividend Payments slumped 33.33% in 2016 and jumped 50.0% in 2017, its largest moves.
- Tracing CATX's Preferred Dividend Payments over 5 years: stood at $2000.0 in 2016, then jumped by 50.0% to $3000.0 in 2017, then sank by 33.33% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then jumped by 50.0% to $3000.0 in 2020.
- Business Quant data shows CATX's Preferred Dividend Payments at $3000.0 in Q3 2020, $3000.0 in Q2 2020, and $3000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 3,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 3,000.00 |
| Mar 31, 2017 | 3,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 3,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Dec 31, 2015 | 3,000.00 |